Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mixo
- Development stage
- Unknown
- Lead developer
- Maxitech Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MIXO is an oral third-generation cephalosporin antibiotic containing cefixime as the active pharmaceutical ingredient. Developed by Maxitech Pharma, MIXO is approved for the treatment of various bacterial infections, including respiratory tract infections (such as bronchitis, pharyngitis, and tonsillitis), middle ear infections (otitis media), urinary tract infections, and uncomplicated gonorrhea. Cefixime exerts its bactericidal effect by binding to and inhibiting penicillin-binding proteins (PBPs), specifically PBP-1a, PBP-1b, and PBP-3, which are essential for bacterial cell wall peptidoglycan synthesis. This inhibition disrupts cell wall integrity, leading to osmotic instability, cell lysis, and bacterial death. MIXO is stable against many beta-lactamase enzymes, allowing it to remain effective against several resistant bacterial strains.
- Brand names
- Mixo
- Other names
- cefiximecefixime trihydrate
02
Targets
PBP1A (Penicillin-binding protein 1A)PBP1b (Penicillin-binding protein 1B)
Beyond the preview
Go deeper on Mixo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mixo.